Healthcare -
Biotechnology - NASDAQ - US
$ 9.865
-2.23 %
$ 1.02 B
Market Cap
-1.88
P/E
NTLA - CASH & EQUIVALENTS
Cash & Equivalents NTLA - Intellia Therapeutics, Inc.
227 M
LAST VALUE
35.55%
2 YEAR CAGR
30.96%
5 YEAR CAGR
0.00%
10 YEAR CAGR